KUALA LUMPUR, December 20 – DC Healthcare Holdings Berhad, a leading provider of aesthetic medical services, has announced the strategic acquisition of I Bella Sdn Bhd, a move designed to strengthen its service offerings and market presence. The acquisition, valued at RM70.0 million, includes a profit guarantee of RM11.4 million for the financial years ending March 2024 and 2025. DC Healthcare’s commitment to acquiring 100% equity interest in I Bella underscores its confidence in the company’s future financial performance. The payment structure for the acquisition involves a Cash Consideration of RM35.0 million.
With RM15.0 million from the IPO proceeds and the remaining RM20.0 million funded through DC Healthcare’s internally generated funds and/or bank borrowings. Additionally, 60.3 million new ordinary shares in DC Healthcare will be issued at a price of RM0.58 per share. This strategic move is expected to enrich DC Healthcare’s client portfolio, especially among Malay customers, offering services such as facial and skin treatments, and body and face contouring. Dr. Chong Tze Sheng, Managing Director of DC Healthcare, highlighted the significance of the acquisition, stating, “The acquisition of I Bella is a key milestone in our growth strategy.
It expands our service range and strengthens our commitment to excellence in aesthetic medical services. Integrating I Bella’s expertise, especially their strong foothold in the Malay market segment, will create synergies that enhance our competitive position. Shermine Then, Director and CEO of I Bella, expressed excitement about the alliance, stating, This union with DC Healthcare heralds an exciting era of growth and innovation for I Bella. We are thrilled to integrate our unique expertise in serving a distinct client demographic into DC Healthcare’s extensive network.
Our synergistic collaboration is set to redefine the aesthetic medicine landscape, enhancing service delivery and reaching new milestones in customer satisfaction and market presence. As of November 21, 2023, the share price of DC Healthcare stands at RM0.50 per share, reflecting a market capitalization of RM503.1 million and indicating strong market confidence in the Group’s strategic direction and growth potential.
